Retractable Technologies, Inc. (RVP)
- Previous Close
0.8989 - Open
0.9000 - Bid 0.7912 x 1000
- Ask 0.8400 x 1100
- Day's Range
0.7101 - 0.9000 - 52 Week Range
0.7100 - 1.3400 - Volume
862,141 - Avg. Volume
84,593 - Market Cap (intraday)
23.324M - Beta (5Y Monthly) 2.07
- PE Ratio (TTM)
-- - EPS (TTM)
-0.6000 - Earnings Date Nov 12, 2024 - Nov 18, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.
www.retractable.comRecent News: RVP
View MorePerformance Overview: RVP
Trailing total returns as of 9/20/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RVP
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RVP
View MoreValuation Measures
Market Cap
23.32M
Enterprise Value
-16.96M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.61
Price/Book (mrq)
0.27
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-46.71%
Return on Assets (ttm)
-4.48%
Return on Equity (ttm)
-18.91%
Revenue (ttm)
38.25M
Net Income Avi to Common (ttm)
-18.1M
Diluted EPS (ttm)
-0.6000
Balance Sheet and Cash Flow
Total Cash (mrq)
41.9M
Total Debt/Equity (mrq)
1.62%
Levered Free Cash Flow (ttm)
7.4M